MannKind Corp.
Key Metrics
Market Snapshot
About
MannKind develops and commercializes Afrezza, an inhaled insulin therapy for adults with diabetes. The biopharmaceutical company focuses on Technosphere drug delivery technology for pulmonary administration of therapeutic compounds.